2013
DOI: 10.1016/j.intimp.2013.07.025
|View full text |Cite
|
Sign up to set email alerts
|

An approach to local immunotoxicity induced by adjuvanted vaccines

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
32
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(34 citation statements)
references
References 120 publications
1
32
0
Order By: Relevance
“…Each used vaccine in this study differed in its composition. This assumption is confirmed by human studies which displayed different local reactions caused by different adjuvants (Batista-Duharte et al, 2013;Edelman, 1980;Gupta et al, 1993).…”
Section: Discussionsupporting
confidence: 55%
“…Each used vaccine in this study differed in its composition. This assumption is confirmed by human studies which displayed different local reactions caused by different adjuvants (Batista-Duharte et al, 2013;Edelman, 1980;Gupta et al, 1993).…”
Section: Discussionsupporting
confidence: 55%
“…In human medicine magnetic resonance imaging (MRI) is an approved method for diagnosis and follow-up of musculoskeletal diseases (Kuo and Carrino, 2007;Messineo et al, 1998;Schedel et al, 1992;Walker, 2008;Young and Bydder, 2003). MRI has been used in mice to evaluate antigen clearance after vaccination (Brewer et al, 2014).…”
Section: Introductionmentioning
confidence: 99%
“…174 The scientific literature contains reports of several hundred adjuvants with efficacy profiles that could be better than most adjuvants that currently approved for use in licensed vaccines, but none of these are clinically relevant because of their unsatisfactory safety profiles. 12,100 From this perspective, the potential of LVA for use in human vaccines is supported by evidence from the preclinical and clinical studies and a compelling safety profile. In the most recent published study, LVA doses equivalent to those shown to be immunogenic in mice were tolerable in humans and did not appear to cause any skin damage.…”
Section: Discussionmentioning
confidence: 99%
“…99 Unfortunately, this persistence of inflammatory signaling may also play a role in diminishing the safety of these adjuvants. 12,100 LVAs appear to function quite distinctly from chemical adjuvants in that they result in tissue signaling and the activation of APCs, but do not appear to trigger significant inflammatory responses. Chen et al reported that the activation and migration of APCs in the skin following 532 nm Q-Nd:YAG laser treatment was not accompanied by a significant increase in inflammatory cytokines including TNF-α, IL-1β, IL-6, and CCL2.…”
mentioning
confidence: 99%